From pioneering infection diagnostics to innovative therapies, explore the latest advancements in Staphylococcus aureus research that drive precision in infection management.
Explore our preclinical study unveiling the potential of fully-human monoclonal antibody 1D9. Precision-designed to target the immunodominant staphylococcal antigen A (IsaA), offering promising therapeutic insights.
Dive into the potential of fluorescently labeled vancomycin (vanco-800CW) as a targeted tool for detecting Gram-positive bacterial infections. Explore innovative approaches to infection detection and diagnosis.